Dedifferentiation Precedes Invasion in the Progression from Barrett's Metaplasia to Esophageal Adenocarcinoma
Authors:
Open Access
- 1 April 2005
- journal article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 11 (7) , 2478-2485
Abstract
Purpose: Adenocarcinoma arises in Barrett's esophagus by progression from metaplasia to cancer through grades of dysplasia. Our aim in this exploratory study was to characterize the broad changes in gene expression that underlie this histologic progression to cancer and assess the potential for using these gene expression changes as a marker predictive of malignant progression in Barrett's epithelium.Keywords
This publication has 28 references indexed in Scilit:
- Biomarkers of Esophageal Adenocarcinoma and Barrett’s EsophagusCancer Research, 2004
- Hallmarks of cancer progression in Barrett's oesophagusThe Lancet, 2002
- Gastroesophageal Reflux, Barrett Esophagus, and Esophageal CancerJAMA, 2002
- Global gene expression profiling in Barrett's esophagus and esophageal cancer: a comparative analysis using cDNA microarraysOncogene, 2002
- Patterning Mechanisms Controlling Vertebrate Limb DevelopmentAnnual Review of Cell and Developmental Biology, 2001
- Angiogenesis and Angiogenesis Inhibitors: a New Potential Anticancer Therapeutic StrategyCurrent Drug Target - Immune, Endocrine & Metabolic Disorders, 2001
- Gene Expression Profiling in Human Esophageal Cancers Using cDNA MicroarrayBiochemical and Biophysical Research Communications, 2001
- Chromosomal Imbalances in Barrett's Adenocarcinoma and the Metaplasia-Dysplasia-Carcinoma SequenceThe American Journal of Pathology, 2000
- The columnar-lined esophagus, intestinal metaplasia, and Norman BarrettGastroenterology, 1996
- Adenocarcinoma of the Lower EsophagusJournal of Clinical Gastroenterology, 1986